Aspira Women’s Health Expands Lab to Advance ENDOinform Test
Austin, Texas, USA – April 23, 2026 Aspira Women’s Health announced a major operational milestone with the expansion of...
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Austin, Texas, USA – April 23, 2026 Aspira Women’s Health announced a major operational milestone with the expansion of...
Seattle, Washington, USA & Brisbane, Australia – April 23, 2026 Mozart Therapeutics announced positive interim Phase 1b clinical data...
CAMBRIDGE, Mass., Sept. 25, 2025 — Intellia Therapeutics announced positive longer-term Phase 1 data for its investigational CRISPR-based therapy...
